Bio-Techne has announced an upcoming webinar focused on modernizing and accelerating clonal cell line development workflows through automation and high-throughput imaging technologies. The session, titled “Faster Clonal Cell Line Development: Automation Meets High-Throughput Imaging,” will explore how integrated, data-driven approaches are reshaping one of the most critical and time-consuming steps in biotherapeutic research and production.
Clonal cell line generation underpins a wide range of applications, including cancer research, drug discovery, and biotherapeutics manufacturing. However, traditional techniques—such as limiting dilution assays (LDA)—are often slow, labor-intensive, and prone to variability. These limitations can delay development timelines and reduce confidence in clonality and data traceability.
Rethinking traditional workflows
In conventional clonal workflows, researchers often rely on manual processes for single-cell isolation and verification. While effective, these methods can introduce subjectivity, increase hands-on time, and make it challenging to scale studies or meet increasing regulatory expectations.
This webinar will demonstrate how combining:
- Automated single-cell dispensing, and
- Automated, high-throughput imaging platforms
creates a streamlined workflow that improves efficiency, reproducibility, and documentation. By integrating dispensing and imaging into a single, cohesive pipeline, researchers can significantly reduce development time while strengthening confidence in clonality and downstream decision-making.
What attendees will learn
Participants will gain practical insights into how automation transforms clonal cell line development, including how to:
- Replace manual, labor-intensive steps with automated, reproducible workflows
- Increase throughput while maintaining high confidence in single-cell origin
- Use automated imaging to document clonality over time, supporting audit readiness and data integrity
- Reduce variability and subjectivity in clone selection
- Accelerate timelines in early research while supporting scalable, production-ready processes
The webinar emphasizes a data-driven approach, showing how integrated automation not only speeds up workflows but also improves traceability and robustness across research and production environments.
Event details
- Date: February 26, 2026
- Session 1: 5:00 AM PST | 8:00 AM EST | 2:00 PM CET
- Session 2: 8:00 AM PST | 11:00 AM EST | 5:00 PM CET
- Format: Live online webinar (registration required)
Two sessions are offered to accommodate global audiences across multiple time zones.
Speakers
The webinar will be led by experts from Bio-Techne and SYNENTEC:
- Ryan McComb, Ph.D.
Senior Product Manager at Bio-Techne, with extensive experience in product strategy and solutions supporting advanced cell biology workflows. - Benjamin Werdelmann
Director of Business Development & Applications at SYNENTEC GmbH, bringing deep expertise in automated cell cloning technologies and applied imaging solutions.
About Bio-Techne
Bio-Techne is a global developer, manufacturer, and supplier of high-quality reagents, analytical instruments, and precision diagnostics. Its portfolio includes well-known brands such as R&D Systems™, Novus Biologicals™, Tocris Bioscience™, ProteinSimple™, ACD™, Asuragen®, and Lunaphore™, supporting researchers across life sciences, diagnostics, and biopharmaceutical development.
This webinar is particularly relevant for scientists, process development teams, and decision-makers seeking to modernize clonal workflows, improve reproducibility, and reduce time to results in both research and manufacturing settings.